LiveGMP
LiveGMP
The Grey Market Premium for this IPO is currently showing steady interest.
Cautious approach recommended for retail investors.
Details about Mahamaya Lifesciences are not yet available.
Investors looking at the Mahamaya Lifesciences IPO are closely monitoring the Grey Market Premium (GMP) to gauge potential listing gains. Being a SME IPO, Mahamaya Lifesciences has attracted significant attention from both retail and institutional investors.
On this page, we provide real-time updates for Mahamaya Lifesciences GMP, live subscription status, and day-wise premium history. Our goal is to help you decide whether to apply for Mahamaya Lifesciences IPO based on fundamentals, market sentiment, and AI-powered analysis.
Track how many times Mahamaya Lifesciences is subscribed across Retail, HNI, and QIB categories. High subscription often leads to higher GMP and listing gains.
Based on the current GMP of Mahamaya Lifesciences, calculate your potential profit per lot. Remember, GMP is indicative and the actual listing price may vary.
Always check the RHP (Red Herring Prospectus) of Mahamaya Lifesciences on the SEBI website for officially audited financials and risk factors before investing.
How to check Mahamaya Lifesciences IPO Allotment Status?
You can check the allotment status for Mahamaya Lifesciences on our Allotment Page once the registrar finalizes the basis of allotment.
What is the lot size for Mahamaya Lifesciences?
The lot size and price band for Mahamaya Lifesciences are available in the overview table above. Typically, one lot for a SME IPO costs between ₹14,000 to ₹15,000 for retail investors.